- Home
- VREX vs VSTM Comparison
VREX vs VSTM Comparison
Compare VREX & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VREX
- VSTM
- Stock Information
- Founded
- VREX 2016
- VSTM 2010
- Country
- VREX United States
- VSTM United States
- Employees
- VREX N/A
- VSTM N/A
- Industry
- VREX Industrial Machinery/Components
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- VREX Technology
- VSTM Health Care
- Exchange
- VREX Nasdaq
- VSTM Nasdaq
- Market Cap
- VREX 343.3M
- VSTM 345.6M
- IPO Year
- VREX N/A
- VSTM 2012
- Fundamental
- Price
- VREX $7.18
- VSTM $6.08
- Analyst Decision
- VREX Strong Buy
- VSTM Strong Buy
- Analyst Count
- VREX 2
- VSTM 9
- Target Price
- VREX $22.50
- VSTM $12.63
- AVG Volume (30 Days)
- VREX 300.4K
- VSTM 2.3M
- Earning Date
- VREX 08-07-2025
- VSTM 08-07-2025
- Dividend Yield
- VREX N/A
- VSTM N/A
- EPS Growth
- VREX N/A
- VSTM N/A
- EPS
- VREX N/A
- VSTM N/A
- Revenue
- VREX $827,500,000.00
- VSTM $10,000,000.00
- Revenue This Year
- VREX $0.73
- VSTM $55.63
- Revenue Next Year
- VREX $4.40
- VSTM $453.72
- P/E Ratio
- VREX N/A
- VSTM N/A
- Revenue Growth
- VREX N/A
- VSTM N/A
- 52 Week Low
- VREX $6.76
- VSTM $2.10
- 52 Week High
- VREX $16.93
- VSTM $9.10
- Technical
- Relative Strength Index (RSI)
- VREX 36.46
- VSTM 61.98
- Support Level
- VREX $7.22
- VSTM $5.78
- Resistance Level
- VREX $8.09
- VSTM $6.78
- Average True Range (ATR)
- VREX 0.37
- VSTM 0.48
- MACD
- VREX -0.05
- VSTM 0.16
- Stochastic Oscillator
- VREX 31.58
- VSTM 64.65
About VREX Varex Imaging Corporation
Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.